Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The organisms that cause malaria in humans are single-celled protozoan parasites of the genus Plasmodium. The most significant and deadly species is *Plasmodium falciparum*, but *P. vivax*, *P. malariae*, *P. ovale*, and more recently *P. knowlesi* also infect humans. Transmission occurs via the bite of infected *Anopheles* mosquitoes, which inject sporozoites into the host; these enter liver cells, undergo a developmental cycle, then infect red blood cells, leading to the disease manifestations. Severe malaria, mostly from *P. falciparum*, can result in complications like cerebral malaria, severe anemia, multi-organ failure, especially in children and pregnant women[2][4][7][8].
Inhibition of heme detoxification (e.g., chloroquine) Inhibition of mitochondrial electron transport (atovaquone) Generation of free radicals, damaging parasite proteins (artemisinins) Interference with parasite DNA replication or mitochondrial function (primaquine, tafenoquine)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium species that cause malaria in humans.